Europe PMC

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

Abstract 


The effectiveness of nitrofurantoin in suppressing bacterial growth in the urinary tract was evaluated by using two different experimental models. Pyelonephritis was produced in rats by direct inoculation of 10(4)Escherichia coli in the medulla of left kidney. Ascending urinary tract infection was induced by inoculation into the urinary bladder of 10(7)Proteus mirabilis, after a partial cystectomy. Nitrofurantoin was shown to be effective in suppressing bladder bacteriuria, in preventing ascending pyelonephritis, and also in preventing bacterial multiplication in kidney tissue following direct inoculation.

Free full text 


Logo of applmicroLink to Publisher's site
Appl Microbiol. 1969 Oct; 18(4): 547–549.
PMCID: PMC378032
PMID: 4905033

Site of Action of Nitrofurantoin in Experimental Urinary Tract Infection

Abstract

The effectiveness of nitrofurantoin in suppressing bacterial growth in the urinary tract was evaluated by using two different experimental models. Pyelonephritis was produced in rats by direct inoculation of 104Escherichia coli in the medulla of left kidney. Ascending urinary tract infection was induced by inoculation into the urinary bladder of 107Proteus mirabilis, after a partial cystectomy. Nitrofurantoin was shown to be effective in suppressing bladder bacteriuria, in preventing ascending pyelonephritis, and also in preventing bacterial multiplication in kidney tissue following direct inoculation.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (435K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • BUZARD JA, BENDER RC, NOHLE EG, HUMPHREY DT, PAUL MF. Renal tubular transport of nitrofurantoin. Am J Physiol. 1962 Jun;202:1136–1140. [Abstract] [Google Scholar]
  • Currie GA, Little PJ, McDonald SJ. The localisation of cephaloridine and nitrofurantoin in the kidney. Nephron. 1966;3(5):282–288. [Abstract] [Google Scholar]
  • KATZ YJ, COCKETT AT, MOORE RS. RENAL LYMPH AND ANTIBACTERIAL LEVELS IN THE TREATMENT OF PYELONEPHRITIS. Life Sci. 1964 Nov;3:1249–1262. [Abstract] [Google Scholar]
  • Rocha H, Barros M. Experimental pyelonephritis: characteristics of infection in rats following reduction of bladder capacity. Proc Soc Exp Biol Med. 1965 Oct;120(1):122–124. [Abstract] [Google Scholar]
  • WOODRUFF MW, MALVIN RL, THOMPSON IM. The renal transport of nitrofurantoin. Effect of acid-base balance upon its excretion. JAMA. 1961 Apr 1;175:1132–1135. [Abstract] [Google Scholar]

Articles from Applied Microbiology are provided here courtesy of American Society for Microbiology (ASM)